William W. Crouse

InfaCare Pharmaceutical Corp. develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a heme oxygenase inhibitor for the treatment of infantile jaundice or hyperbilirubinemia. The company was founded by Robert A. Vukovich on July 5, 2005 and is headquartered in Trevose, PA.

InfaCare Pharmaceutical Corp. develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a heme oxygenase inhibitor for the treatment of infantile jaundice or hyperbilirubinemia. The company was founded by Robert A. Vukovich on July 5, 2005 and is headquartered in Trevose, PA.

Encore Dermatology, Inc. manufactures prescription therapies and medical devices for dermatologists. It offers hylatopicplus emollient foam, hylatopicplus cream, and tetrix cream to manage and relieve the burning, itching, and pain. The company was founded Robert J. Moccia and Michael Brown in 2015 and is headquartered in Malvern, PA.

Ventria Bioscience, Inc. operates as a biopharmaceutical company. It offers Express Tec., a plant based recombinant protein supplement. The firm also offers controlling zoonotic disease and also provides access to its platform technology through contract manufacturing services. The company was founded by Raymond L. Rodriguez, Peter Matlock and William J. Rutter in 1993 and is headquartered in Fort Collins, CO.

EUSA Pharma (UK) Ltd. supplies medicines and medical devices. It offers Caphosol, Xenazine, Collatamp, Custodiol, and Fomepizole. The company was founded in March 2015 and is headquartered in Hemel Hempstead, the United Kingdom.

Ventria Bioscience, Inc. operates as a biopharmaceutical company. It offers Express Tec., a plant based recombinant protein supplement. The firm also offers controlling zoonotic disease and also provides access to its platform technology through contract manufacturing services. The company was founded by Raymond L. Rodriguez, Peter Matlock and William J. Rutter in 1993 and is headquartered in Fort Collins, CO.

Ventria Bioscience, Inc. operates as a biopharmaceutical company. It offers Express Tec., a plant based recombinant protein supplement. The firm also offers controlling zoonotic disease and also provides access to its platform technology through contract manufacturing services. The company was founded by Raymond L. Rodriguez, Peter Matlock and William J. Rutter in 1993 and is headquartered in Fort Collins, CO.

EUSA Pharma (UK) Ltd. supplies medicines and medical devices. It offers Caphosol, Xenazine, Collatamp, Custodiol, and Fomepizole. The company was founded in March 2015 and is headquartered in Hemel Hempstead, the United Kingdom.

Ventria Bioscience, Inc. operates as a biopharmaceutical company. It offers Express Tec., a plant based recombinant protein supplement. The firm also offers controlling zoonotic disease and also provides access to its platform technology through contract manufacturing services. The company was founded by Raymond L. Rodriguez, Peter Matlock and William J. Rutter in 1993 and is headquartered in Fort Collins, CO.

Ventria Bioscience, Inc. operates as a biopharmaceutical company. It offers Express Tec., a plant based recombinant protein supplement. The firm also offers controlling zoonotic disease and also provides access to its platform technology through contract manufacturing services. The company was founded by Raymond L. Rodriguez, Peter Matlock and William J. Rutter in 1993 and is headquartered in Fort Collins, CO.

Ventria Bioscience, Inc. operates as a biopharmaceutical company. It offers Express Tec., a plant based recombinant protein supplement. The firm also offers controlling zoonotic disease and also provides access to its platform technology through contract manufacturing services. The company was founded by Raymond L. Rodriguez, Peter Matlock and William J. Rutter in 1993 and is headquartered in Fort Collins, CO.

EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade.

Jazz Pharmaceuticals UK Ltd. is pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, oncology supportive care and critical care products. The company was founded in 2006 and is headquartered in Oxford, United Kingdom.

InfaCare Pharmaceutical Corp. develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a heme oxygenase inhibitor for the treatment of infantile jaundice or hyperbilirubinemia. The company was founded by Robert A. Vukovich on July 5, 2005 and is headquartered in Trevose, PA.

Ventria Bioscience, Inc. operates as a biopharmaceutical company. It offers Express Tec., a plant based recombinant protein supplement. The firm also offers controlling zoonotic disease and also provides access to its platform technology through contract manufacturing services. The company was founded by Raymond L. Rodriguez, Peter Matlock and William J. Rutter in 1993 and is headquartered in Fort Collins, CO.

InfaCare Pharmaceutical Corp. develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a heme oxygenase inhibitor for the treatment of infantile jaundice or hyperbilirubinemia. The company was founded by Robert A. Vukovich on July 5, 2005 and is headquartered in Trevose, PA.

Ventria Bioscience, Inc. operates as a biopharmaceutical company. It offers Express Tec., a plant based recombinant protein supplement. The firm also offers controlling zoonotic disease and also provides access to its platform technology through contract manufacturing services. The company was founded by Raymond L. Rodriguez, Peter Matlock and William J. Rutter in 1993 and is headquartered in Fort Collins, CO.

InfaCare Pharmaceutical Corp. develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a heme oxygenase inhibitor for the treatment of infantile jaundice or hyperbilirubinemia. The company was founded by Robert A. Vukovich on July 5, 2005 and is headquartered in Trevose, PA.

Encore Dermatology, Inc. manufactures prescription therapies and medical devices for dermatologists. It offers hylatopicplus emollient foam, hylatopicplus cream, and tetrix cream to manage and relieve the burning, itching, and pain. The company was founded Robert J. Moccia and Michael Brown in 2015 and is headquartered in Malvern, PA.

EUSA Pharma (UK) Ltd. supplies medicines and medical devices. It offers Caphosol, Xenazine, Collatamp, Custodiol, and Fomepizole. The company was founded in March 2015 and is headquartered in Hemel Hempstead, the United Kingdom.

Ventria Bioscience, Inc. operates as a biopharmaceutical company. It offers Express Tec., a plant based recombinant protein supplement. The firm also offers controlling zoonotic disease and also provides access to its platform technology through contract manufacturing services. The company was founded by Raymond L. Rodriguez, Peter Matlock and William J. Rutter in 1993 and is headquartered in Fort Collins, CO.

Encore Dermatology, Inc. manufactures prescription therapies and medical devices for dermatologists. It offers hylatopicplus emollient foam, hylatopicplus cream, and tetrix cream to manage and relieve the burning, itching, and pain. The company was founded Robert J. Moccia and Michael Brown in 2015 and is headquartered in Malvern, PA.

EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade.

Encore Dermatology, Inc. manufactures prescription therapies and medical devices for dermatologists. It offers hylatopicplus emollient foam, hylatopicplus cream, and tetrix cream to manage and relieve the burning, itching, and pain. The company was founded Robert J. Moccia and Michael Brown in 2015 and is headquartered in Malvern, PA.

Ventria Bioscience, Inc. operates as a biopharmaceutical company. It offers Express Tec., a plant based recombinant protein supplement. The firm also offers controlling zoonotic disease and also provides access to its platform technology through contract manufacturing services. The company was founded by Raymond L. Rodriguez, Peter Matlock and William J. Rutter in 1993 and is headquartered in Fort Collins, CO.

Ventria Bioscience, Inc. operates as a biopharmaceutical company. It offers Express Tec., a plant based recombinant protein supplement. The firm also offers controlling zoonotic disease and also provides access to its platform technology through contract manufacturing services. The company was founded by Raymond L. Rodriguez, Peter Matlock and William J. Rutter in 1993 and is headquartered in Fort Collins, CO.

Ventria Bioscience, Inc. operates as a biopharmaceutical company. It offers Express Tec., a plant based recombinant protein supplement. The firm also offers controlling zoonotic disease and also provides access to its platform technology through contract manufacturing services. The company was founded by Raymond L. Rodriguez, Peter Matlock and William J. Rutter in 1993 and is headquartered in Fort Collins, CO.